Tamai M - Search Results

1

In vitro augmentation of cytotoxic activity of peripheral blood lymphocytes and spleen cells of cancer patients by ubenimex.

Iwahashi M, Tanimura H, Yamaue H, Tsunoda T, Tani M, Noguchi K, Mizobata S, Tamai M, Hotta T, Arii K, et al. Iwahashi M, et al. Among authors: tamai m. Anticancer Res. 1994 Jul-Aug;14(4A):1557-62. Anticancer Res. 1994. PMID: 7979185

2

Enhancement of tumor cell susceptibility to lymphokine-activated killer cells by treatment with the streptococcal preparation OK432.

Yamaue H, Tanimura H, Tsunoda T, Iwahashi M, Tani M, Tamai M, Noguchi K, Hotta T, Arii K. Yamaue H, et al. Among authors: tamai m. Biotherapy. 1992;5(1):83-93. doi: 10.1007/BF02194788. Biotherapy. 1992. PMID: 1389905

3

Defective autologous mixed lymphocyte reaction (AMLR) and killer activity generated in the AMLR in cancer patients.

Iwahashi M, Tanimura H, Yamaue H, Tsunoda T, Tani M, Tamai M, Noguchi K, Hotta T. Iwahashi M, et al. Among authors: tamai m. Int J Cancer. 1992 Apr 22;51(1):67-71. doi: 10.1002/ijc.2910510114. Int J Cancer. 1992. PMID: 1532952

4

The promotive effect of interleukin 4 with interleukin 2 in the proliferation of tumor-infiltrating lymphocytes from patients with malignant tumor.

Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Arii K, Noguchi K. Tsunoda T, et al. Among authors: tamai m. Biotherapy. 1992;4(1):9-15. doi: 10.1007/BF02171704. Biotherapy. 1992. PMID: 1543654

5

In vitro augmentation of the cytotoxic activity of peripheral blood mononuclear cells and tumor-infiltrating lymphocytes by famotidine in cancer patients.

Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Arii K, Noguchi K. Tsunoda T, et al. Among authors: tamai m. Int J Immunopharmacol. 1992 Jan;14(1):75-81. doi: 10.1016/0192-0561(92)90107-v. Int J Immunopharmacol. 1992. PMID: 1582736

6

In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan.

Tani M, Tanimura H, Yamaue H, Iwahashi M, Tsunoda T, Tamai M, Noguchi K, Arii K. Tani M, et al. Among authors: tamai m. Eur J Clin Pharmacol. 1992;42(6):623-7. doi: 10.1007/BF00265926. Eur J Clin Pharmacol. 1992. PMID: 1623902

7

Cisplatin treatment renders tumor cells more susceptible to attack by lymphokine-activated killer cells.

Yamaue H, Tanimura H, Noguchi K, Iwahashi M, Tsunoda T, Tani M, Tamai M, Hotta T, Mizobata S, Arii K. Yamaue H, et al. Among authors: tamai m. J Clin Lab Immunol. 1991 Aug;35(4):165-70. J Clin Lab Immunol. 1991. PMID: 1668852

8

Functional and phenotypic analyses of interleukin 2-activated tumor-infiltrating lymphocytes.

Yamaue H, Tanimura H, Tsunoda T, Iwahashi M, Tani M, Tamai M, Inoue M. Yamaue H, et al. Among authors: tamai m. Biotherapy. 1990;2(3):247-59. doi: 10.1007/BF02173526. Biotherapy. 1990. PMID: 1698423

9

Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma.

Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Noguchi K, Arii K, Hotta T. Tsunoda T, et al. Among authors: tamai m. Nihon Geka Hokan. 1991 Nov 1;60(6):396-405. Nihon Geka Hokan. 1991. PMID: 1820012

10

Impairment of autologous mixed lymphocyte reaction in the spleen and peripheral blood lymphocytes of patients with idiopathic portal hypertension.

Yamaue H, Tanimura H, Iwahashi M, Tsunoda T, Tani M, Tamai M, Inoue M. Yamaue H, et al. Among authors: tamai m. Gastroenterol Jpn. 1990 Apr;25(2):193-8. doi: 10.1007/BF02776815. Gastroenterol Jpn. 1990. PMID: 2140807

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

912 results

Search Page

Filters